Angiogenesis inhibitors are a class of therapeutic agents that disrupt the process of angiogenesis, which is the formation of new blood vessels from pre-existing ones. This process is crucial in both normal physiological conditions, such as wound healing and embryogenesis, and in pathological conditions, such as cancer and diabetic retinopathy.
